Ibyerekeye-kanseri / kuvura / ibiyobyabwenge / melanoma

Ibiyobyabwenge Byemewe kuri Melanoma

Uru rupapuro rugaragaza imiti ya kanseri yemejwe n’ubuyobozi bushinzwe ibiryo n'ibiyobyabwenge (FDA) kuri melanoma. Urutonde rurimo amazina rusange nizina ryikirango. Amazina yibiyobyabwenge ahuza incamake yamakuru ya Kanseri ya NCI. Hashobora kuba hari imiti ikoreshwa muri melanoma itanditswe hano.

Ibiyobyabwenge Byemewe kuri Melanoma

Aldesleukin

Binimetinib

Braftovi (Encorafenib)

Cobimetinib

Cotellic (Cobimetinib)

Dabrafenib Mesylate

Dacarbazine

Encorafenib

IL-2 (Aldesleukin)

Imlygic (Talimogene Laherparepvec)

Interleukin-2 (Aldesleukin)

Intangiriro A (Recombinant Interferon Alfa-2b)

Ipilimumab

Keytruda (Pembrolizumab)

Mekinist (Trametinib)

Mektovi (Binimetinib)

Nivolumab

Opdivo (Nivolumab)

Peginterferon Alfa-2b

PEG-Intron (Peginterferon Alfa-2b)

Pembrolizumab

Proleukin (Aldesleukin)

Recombinant Interferon Alfa-2b

Sylatron (Peginterferon Alfa-2b)

Tafinlar (Dabrafenib Mesylate)

Talimogene Laherparepvec

Trametinib

Vemurafenib

Yervoy (Ipilimumab)

Zelboraf (Vemurafenib)